Fluid media such as Cohen-Wheeler medium and semi-synthetic media containing charcoal are niow replacing the classical Bordet-Gengou medium in the productionl of pertussis vaccine. But since pertussis vaccine made by the Michigan Department of Health Laboratories from growth on Bordet-Gengou medium has been repeatedly demonstrated in field trials to give a high degree of protection, most recently by the Medical Research Council Inivestigation (1951) of England, we, in this laboratory, continiue to use BordetGengou medium.
Normally, sheep blood is added to the Bordet-Gengou agar base. Owing to the difficulty of obtaining such large amounts of sheep blood needed for the preparation of vaccine media in Formosa, our attention has been directed to findinig other animal blood as a suitable substitute. Cow's blood was selected for study because it is easily obtainiable from local markets and calves previously used for the productioni of small pox vaccinie might serv,e as a source.
Because Our vaccines, derived from Bordet-Gengou medium containing cow's blood, were all able to stand comparison in potency with the lot of Michigan Department of Health vaccine used for reference. The potency of lots SS # 5, # 6 and # 8, # 9 combined were slightly lower than the reference vaccine, but the differences were not statistically significant. The comparison of potencies is on a per bacterium basis and, therefore, cannot be directly interpreted in terms of the present NIH (USA) requirements which are based on mouse protective units per total human dose.
Toxicity tests. The toxicity tests were done according to the National Institutes of Health minimum requirements for pertussis vaccine (National Institutes of Health, 1952) except that a larger dosage was used than required. In all instances the mice gained weight after seven days, and all the vaccines passed the toxicity tests.
DISCUSSION
We can see from the above results that the production of pertussis vaccine from Bordet-Gengou medium containing cow's blood presented no difficulty in either of the three important features that is, growth, potency and toxicity.
For laboratories where sheep's blood is not readily available, this substitution of cow's blood may prove to be of interest. One may question the hazards of using blood from calves that had been used for the production of small pox vaccine. It is accepted that in general any animals used as blood source should be healthy. They should be free of tuberculosis, brucellosis, Q fever, foot and mouth disease and any other diseases. The question here is whether the blood might contain vaccinia virus.
The interval between planting of vaccinia virus and drawing of blood (just before harvest of vaccine) was eight days. After the routine sterility test of the sublots, the stock suspension was tested for vaccinia virus by inoculation of 0.1 ml into each of 10 eggs. In all instances these tests were negative, indicating that in the final product, at least, no living virus could be detected by methods employed.
In our experielnce with 50,000 children immunized with diphtheria-tetanus-pertussis (DTP) vaccine in which the pertussis component was so prepared, no untoward result was observed. Further studies are being made on the side reactions and immunological responses following vaccination in selected human groups.
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